Rising Star: Davis Polk's Neal Potischman

Law360, Philadelphia (March 14, 2013, 5:35 PM EDT) -- For successfully helming several of Davis Polk & Wardwell LLP's most high-profile assignments recently, including defeating class certification in a group of cases over off-label marketing of a Pfizer Inc. seizure medication, Neal Potischman has earned a spot among Law360's five rising stars in class action law.

Potischman led the David Polk briefing team responsible for crafting the legal argument that convinced a Massachusetts federal judge to deny class certification to plaintiffs seeking damages in multidistrict litigation over off-label promotion of Pfizer's Neurontin, an anti-seizure medication...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.